Purchase Order 36C26326P0309

Edwards Lifesciences LLC, a subsidiary of the global medical device manufacturer Edwards Lifesciences Corporation, received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis, MN) on March 13, 2026, for transcatheter aortic valve replacement (TAVR) systems. The contract, which represents a child award under Edwards Lifesciences LLC's broader framework agreements with the Department of Veterans Affairs, carries no set-aside designation and is scheduled for completion by March 16, 2026. As a self-certified small disadvantaged business, Edwards Lifesciences LLC supplies specialized cardiovascular medical devices, including SAPIEN transcatheter heart valves and related cardiac technologies, that support the VA's mission to provide advanced cardiac care to the veteran population.

This purchase order exemplifies Edwards Lifesciences LLC's extensive relationship with the VA healthcare system, wherein the company has received over 200 prime contract awards since 2025, predominantly through individual purchase orders issued across multiple VISNs. The company operates under two primary indefinite delivery contracts totaling $7.45 million—a $6.5 million five-year consignment agreement with VISN 21 (Palo Alto) and a $950,000 five-year supply contract with VISN 15—which establish Edwards Lifesciences LLC as the primary framework supplier of advanced cardiovascular devices for VA surgical programs. These structured arrangements ensure consistent availability of specialized implants and transcatheter valves essential to veteran cardiac surgical outcomes across the VA's integrated service networks.